Medcity Converge 2018 Philadelphia: Live Coverage @pharma_BI
Stephen J. Williams: Reporter
3.3.3 Medcity Converge 2018 Philadelphia: Live Coverage @pharma_BI, Volume 2 (Volume Two: Latest in Genomics Methodologies for Therapeutics: Gene Editing, NGS and BioInformatics, Simulations and the Genome Ontology), Part 2: CRISPR for Gene Editing and DNA Repair
MedCity CONVERGE is a two-day executive summit that gathers innovative thought leaders from across all healthcare sectors to provide actionable insight on where oncology innovation is heading.
On July 11-12, 2018 in Philadelphia, MedCity CONVERGE will gather technology disruptors, payers, providers, life science companies, venture capitalists and more to discuss how AI, Big Data and Precision Medicine are changing the game in cancer. See agenda.
The conference highlights innovation and best practices across the continuum—from research to technological innovation to transformations of treatment and care delivery, and most importantly, patient empowerment—from some of the country’s most innovative healthcare organizations managing the disease.
Meaningful networking opportunities abound, with executives driving the innovation from diverse entities: leading hospital systems, medical device firms, biotech, pharma, emerging technology startups and health IT, as well as the investment community.
Day 1: Wednesday, July 11, 2018
7:30 AM2nd Floor – Paris Foyer |
Registration + Breakfast |
||||||||||||||||||
8:15 AM–8:30 AMParis Ballroom |
Welcome Remarks: Arundhati Parmar, VP and Editor-in-Chief, MedCity News |
||||||||||||||||||
8:30 AM–9:15 AMParis Ballroom |
Practical Applications of AI in CancerWe are far from machine learning dictating clinical decision making, but AI has important niche applications in oncology. Hear from a panel of innovative startups and established life science players about how machine learning and AI can transform different aspects in healthcare, be it in patient recruitment, data analysis, drug discovery or care delivery. Moderator: Ayan Bhattacharya, Advanced Analytics Specialist Leader, Deloitte Consulting LLP |
||||||||||||||||||
9:15 AM–9:45 AMParis Ballroom |
Opening Keynote: Dr. Joshua Brody, Medical Oncologist, Mount Sinai Health SystemThe Promise and Hype of Immunotherapy Immunotherapy is revolutionizing oncology care across various types of cancers, but it is also necessary to sort the hype from the reality. In his keynote, Dr. Brody will delve into the history of this new therapy mode and how it has transformed the treatment of lymphoma and other diseases. He will address the hype surrounding it, why so many still don’t respond to the treatment regimen and chart the way forward—one that can lead to more elegant immunotherapy combination paths and better outcomes for patients. Speaker: |
||||||||||||||||||
9:45 AM–10:00 AMParis Foyer |
Networking Break + Showcase |
||||||||||||||||||
10:00 AM–10:45 AMParis Ballroom |
The Davids vs. the Cancer Goliath Part 1Startups from diagnostics, biopharma, medtech, digital health and emerging tech will have 8 minutes to articulate their visions on how they aim to tame the beast.
Speakers: |
||||||||||||||||||
10:45 AM–11:00 AMParis Foyer |
Networking Break + Showcase |
||||||||||||||||||
11:00 AM–11:45 AMMontpellier – 3rd Floor |
Breakout: Biopharma Gets Its Feet Wet in Digital HealthIn the last few years, biotech and pharma companies have been leveraging digital health tools in everything from oncology trials, medication adherence to patient engagement. What are the lessons learned? Moderator: Anthony Green, Ph.D., Vice President, Technology Commercialization Group, Ben Franklin Technology Partners |
||||||||||||||||||
11:00 AM–11:45 AMParis Ballroom |
Breakout: How to Scale Precision MedicineThe potential for precision medicine is real, but is limited by access to patient datasets. How are government entities, hospitals and startups bringing the promise of precision medicine to the masses of oncology patients Moderator: Sandeep Burugupalli, Senior Manager, Real World Data Innovation, Pfizer @sandeepburug |
||||||||||||||||||
11:50 AM–12:30 PMParis Ballroom |
Fireside Chat with Michael Pellini, M.D.Building a Precision Medicine Business from the Ground Up: An Operating and Venture Perspective Dr. Pellini has spent more than 20 years working on the operating side of four companies, each of which has pushed the boundaries of the standard of care. He will describe his most recent experience at Foundation Medicine, at the forefront of precision medicine, and how that experience can be leveraged on the venture side, where he now evaluates new healthcare technologies. Speaker: |
||||||||||||||||||
12:30 PM–1:30 PMChez Colette Restaurant – Lobby |
Lunch Reception |
||||||||||||||||||
1:30 PM–2:15 PMParis Ballroom |
Clinical Trials 2.0The randomized, controlled clinical trial is the gold standard, but it may be time for a new model. How can patient networks and new technology be leveraged to boost clinical trial recruitment and manage clinical trials more efficiently? Moderator: John Reites, Chief Product Officer, Thread @johnreites |
||||||||||||||||||
2:20 PM–3:00 PMParis Ballroom |
CONVERGEnce on Steroids: Why Comcast and Independence Blue Cross?This year has seen a great deal of convergence in health care. One of the most innovative collaborations announced was that of Cable and Media giant Comcast Corporation and health plan Independence Blue Cross. This fireside chat will explore what the joint venture is all about, the backstory of how this unlikely partnership came to be, and what it might mean for our industry. sponsored by Independence Blue Cross Moderator: Tom Olenzak, Managing Director Strategic Innovation Portfolio, Independence Blue Cross @IBX |
||||||||||||||||||
3:00 PM–3:15 PMParis Foyer |
Networking Break + Showcase |
||||||||||||||||||
3:15 PM–4:00 PMMontpellier – 3rd Floor |
Breakout: Charting the Way Forward in Gene and Cell TherapyThere is a boom underway in cell and gene therapies that are being wielded to tackle cancer and other diseases at the cellular level. FDA has approved a few drugs in the space. These innovations raise important questions about patient access, patient safety, and personalized medicine. Hear from interesting startups and experts about the future of gene therapy. Moderator: Alaric DeArment, Senior Reporter, MedCity News |
||||||||||||||||||
3:15 PM–4:00 PMParis Ballroom |
Breakout: What’s A Good Model for Value-Based Care in Oncology?How do you implement a value-based care model in oncology? Medicare has created a bundled payment model in oncology and there are lessons to be learned from that and other programs. Listen to two presentations from experts in the field. Moderator: Mahek Shah, M.D., Senior Researcher, Harvard Business School @Mahek_MD |
||||||||||||||||||
4:00 PM–4:10 PMParis Foyer |
Networking Break + Showcase |
||||||||||||||||||
4:10 PM–4:55 PMMontpellier – 3rd Floor |
Breakout: Trends in Oncology InvestingA panel of investors interested in therapeutics, diagnostics, digital health and emerging technology will discuss what is hot in cancer investing. Moderator: Stephanie Baum, Director of Special Projects, MedCity News @StephLBaum |
||||||||||||||||||
4:10 PM–4:55 PMParis Ballroom |
Breakout: What Patients Want and Need On Their JourneyCancer patients are living with an existential threat every day. A panel of patients and experts in oncology care management will discuss what’s needed to make the journey for oncology patients a bit more bearable. sponsored by CEO Council for Growth Moderator: Amanda Woodworth, M.D., Director of Breast Health, Drexel University College of Medicine |
||||||||||||||||||
5:00 PM–5:45 PMParis Ballroom |
Early Diagnosis Through Predictive Biomarkers, NonInvasive TestingDiagnosing cancer early is often the difference between survival and death. Hear from experts regarding the new and emerging technologies that form the next generation of cancer diagnostics. Moderator: Heather Rose, Director of Licensing, Thomas Jefferson University |
||||||||||||||||||
5:45 PM–7:00 PMParis Foyer |
Networking Reception |
Day 2: Thursday, July 12, 2018
7:30 AMParis Foyer |
Breakfast + Registration |
||||||||||||||||||
8:30 AM–8:40 AMParis Ballroom |
Opening Remarks: Arundhati Parmar, VP and Editor-in-Chief, MedCity News |
||||||||||||||||||
8:40 AM–9:25 AMParis Ballroom |
The Davids vs. the Cancer Goliath Part 2Startups from diagnostics, biopharma, medtech, digital health and emerging tech will have 8 minutes to articulate their visions on how they aim to tame the beast.
Speakers: |
||||||||||||||||||
9:30 AM–10:15 AMParis Ballroom |
Liquid Biopsy and Gene Testing vs. Reimbursement HurdlesGenetic testing, whether broad-scale or single gene-testing, is being ordered by an increasing number of oncologists, but in many cases, patients are left to pay for these expensive tests themselves. How can this dynamic be shifted? What can be learned from the success stories? Moderator: Shoshannah Roth, Assistant Director of Health Technology Assessment and Information Services , ECRI Institute @Ecri_Institute |
||||||||||||||||||
10:15 AM–10:25 AMParis Foyer |
Networking Break + Showcase |
||||||||||||||||||
10:25 AM–11:10 AMParis Ballroom |
Promising Drugs, Pricing and AccessThe drug pricing debate rages on. What are the solutions to continuing to foster research and innovation, while ensuring access and affordability for patients? Can biosimilars and generics be able to expand market access in the U.S.? Moderator: Bunny Ellerin, Director, Healthcare and Pharmaceutical Management Program, Columbia Business School |
||||||||||||||||||
11:10 AM–11:20 AM |
Networking Break + Showcase |
||||||||||||||||||
11:20 AM–12:05 PMParis Ballroom |
Breaking Down Silos in Research“Silo” is healthcare’s four-letter word. How are researchers, life science companies and others sharing information that can benefit patients more quickly? Hear from experts at institutions that are striving to tear down the walls that prevent data from flowing. Moderator: Vini Jolly, Executive Director, Woodside Capital Partners |
||||||||||||||||||
12:10 PM–12:40 PMParis Ballroom |
Closing Keynote: Anne Stockwell, Cancer Survivor, Founder, Well AgainFinding Your Well Again
Anne Stockwell discusses her mission to help cancer survivors heal their emotional trauma and regain their balance after treatment. A multi-skilled artist as well as a three-time cancer survivor, Anne learned through experience that the emotional impact of cancer often strikes after treatment, isolating a survivor rather than lighting the way forward. Anne realized that her well-trained imagination as an artist was key to her successful reentry after cancer. Now she helps other survivors develop their own creative tools to help them find their way forward with joy.
Speaker: |
||||||||||||||||||
12:40 PM–12:45 PM |
Closing Remarks |
Please follow on Twitter using the following #hashtags and @pharma_BI
#MCConverge
#cancertreatment
#healthIT
#innovation
#precisionmedicine
#healthcaremodels
#personalizedmedicine
#healthcaredata
And at the following handles:
@pharma_BI
@medcitynews
2012pharmaceutical
Amandeep Kaur
Aashir Awan, Phd
Abhisar Anand
Adina Hazan
Alan F. Kaul, PharmD., MS, MBA, FCCP
alexcrystal6
anamikasarkar
apreconasia
aptubman
Arav Gandhi
aviralvatsa
David Orchard-Webb, PhD
danutdaagmailcom
Demet Sag, Ph.D., CRA, GCP
Dror Nir
dsmolyar
Ethan Coomber
evelinacohn
FrasonKalapurackal
Gail S Thornton
Irina Robu
jayzmit48
jdpmd
jshertok
kellyperlman
Ed Kislauskis
larryhbern
Madison Davis
marzankhan
megbaker58
ofermar2020
Dr. Pati
pkandala
ritusaxena
Rick Mandahl
sjwilliamspa
Srinivas Sriram
stuartlpbi
Dr. Sudipta Saha
tildabarliya
zraviv06
zs22
Leave a Reply